Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tom Gallen

Managing Editor – Europe

Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.

Latest From Tom Gallen

Swisse Pens Deal To Use ChromaDex’ Niagen In Supplements

Australian-heritage supplements brand Swisse has secured the rights to use ChromaDex' patented Niagen ingredient - marketed to help consumers "age better" - in a new product range.

Deals China

LATAM Q1 Sales: Mexico's Genomma And Brazil's Hypera Report Gains

Genomma Lab reports OTC sales rise in Q1 thanks to gains in its LATAM region, while Brazil's Hypera posts big jump in turnover due to acquisitions. 

Sales & Earnings Mexico

Germany's Medice Takes Majority Stake in Schaper & Brümmer

Medice has expanded its consumer health offering by taking a 60% stake in German herbal medicines specialist Schaper & Brümmer.

Germany Deals

Nestlé Pens $6bn Deal For The Bountiful Company's Core Brands

Nestlé is poised to add to its Health Science portfolio the Nature's Bounty, Solgar, Osteo Bi-Flex and Puritan’s Pride dietary supplement brands, which generate the majority of their sales in the North American market. 

Dietary Supplements North America

EU Health Claim For Sports Drinks Authorized By Commission

The European Commission has approved a health claim related to carbohydrate solutions used in sports drinks after receiving a positive opinion from EFSA.

Europe Ingredients

Reckitt's OTC Sales Slide 40% In 'Exceptionally Weak' Cold & Flu Season

Reckitt reports major drop in OTC sales in Q1 as the cold and flu season was almost wiped out by social distancing measures related to COVID-19. CEO Laxman Narasimhan reveals he has seen green shoots in certain markets where restrictions have started to relax, insisting "there is no question flu will come back."

Sales & Earnings Dietary Supplements
See All